The Relationship Between Covid-19 and Pneumothorax in Patients Hospitalized With Covid-19 During the Pandemic
- Conditions
- PneumothoraxCOVID-19
- Registration Number
- NCT05677776
- Lead Sponsor
- Erol Olcok Corum Training and Research Hospital
- Brief Summary
It is aimed to examine the retrospective features of covid-19 patients followed in our hospital with pneumothorax.
- Detailed Description
It is aimed to examine the retrospective features of covid-19 patients followed in our hospital with pneumothorax. The files of covid-19 patients with pneumothorax were reviewed retrospectively. The radiological records and treatment protocols of the patients were reviewed. The results were evaluated in terms of its relationship with pneumothorax.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- over 18 years
- covid-19 patient
- having a diagnosis of pneumothorax
- PCR test positive and lung tomography pneumonic involvement
- PCR test negative
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relationship between covid-19 and pneumothorax 1 year Inflammatory markers, C-reactive protein (CRP), lactate dehydrogenase (LDH), ferritin, D-dimer, procalcitonin, blood gas lactate, creatine kinase, white blood cells, baseline laboratory test results including WBC, lymphocyte, neutrophil counts, platelets, urea, creatinine, and neutrophil/lymphocyte ratio were documented for each patient.
Respiratory support status, the fraction of inspired oxygen (FiO2), positive end-expiratory pressure (PEEP) values, tidal volume, and duration of the mechanical ventilator (MV) stay were determined.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hulya TOPCU
🇹🇷Çorum, Turkey